2014, Number 2
<< Back Next >>
Cir Cir 2014; 82 (2)
Pseudomyxoma peritonei. Two-case- report
Carranza-Martínez I, Cornejo-López G, Monroy-Argumedo M, Villanueva-Sáenz E
Language: Spanish
References: 14
Page: 206-211
PDF size: 380.85 Kb.
ABSTRACT
Background: Pseudomyxoma peritonei is a disease characterized by an
intraperitoneal adenomucinous tumor cell disemination, being cecal
appendix the most common etiology.
Objective: To report a surgeon´s group experience and a detailed up
to date literature review.
Clinical cases: 1. A 74 year old woman with a history of four days with
mesogastrium and right lower quadrant abdominal pain associated with
diarrhea and fever was admitted to our institution. Upon admission
she presented with signs of peritoneal irritation and muscular rigidity,
leukocytosis of 14,500 cels/mm
3, 89% neutrophils and 1% bands. An
acute apendicitis diagnosis was established, being scheduled for diagnostic
laparoscopy, during procedure, significant bowel distention was
found, so conversion to laparotomy was required.
Case 2. A 73 year old
male with a history of one year with intermitent abdominal pain at right
iliac fossa and hypogastrium was admitted to our institution. Dyspnea,
constipation alternating with periods of diarrhea, gastric fullness and
heartburn occured. On physical examination only a palpable tumor
occupying mesogastrium and both iliac fossae was noticed, therefore,
a laparotomy was performed.
In both cases diagnoses were made during procedure, finding multiple
scattered multilobulated mucinous tumor implants within the peritoneal
cavity. Histopathological studies confirmed a pseudomyxoma peritonei
diagnoses.
Conclusions: Peritoneal pseudomyxoma is a rare malignant tumor with
a difficult diagnosis characterized by copious production of mucinous
ascites and multiple tumors implants on serosa of intracavitary viscera.
The gold standard treatment consists of cytoreductive surgery and
perioperative intraperitoneal chemotherapy and/or adjuvant
chemotherapy.
REFERENCES
Bevan KE, Mohamed F, Moran BJ. Pseudomyxoma peritonei. World J Gastrointest Oncol 2010;15-2:44-50.
Smeenk RM, Bruin SC, Van Vanvelthuysen ML, Verwall VJ. Pseudomyxoma peritonei. Curr Probl Surg 2008;45:527- 575.
O’Connell JT, Tomlinson JS, Roberts AA, McGonigle KF, Barsky SH. Pseudomyxoma Peritonei Is a Disease of MUC2- Expressing Goblet Cells. Am J Pathol 2002;161:551-564.
Elias D, Honoré C, Ciuchendéa R, Billard V, Raynard B, Lo Dico R, et al. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg 2008;95:1164-1171.
Mukherjee A, Parvaiz A, Cecil TD, Moran BJ. Pseudomyxoma peritonei usually originates from the appendix: a review of the evidence. Eur J Gynaecol Oncol 2004;25:411-414.
Sherer DM, Abulafia O, Eliakim R. Pseudomyxoma peritonei: A Review of Current Literature. Gynecol Obstet Invest 2001;51:73-80.
Hinson FL, Ambrose Mr NS. Pseudomyxoma peritonei. Br J Surg 1998;85:1332-1339.
Smeenk RM, van Velthuysen MLF, Verwaal VJ, Zoetmulder FAN. Appendiceal neoplasms and pseudomyxoma peritonei: A population based study. Eur J Surg Oncol 2008;34:196-201.
Sugarbaker PH. Twenty-Three Years of Progress in the Management of a Rare Disease. Dis Colon Rectum 2011;54:265-266.
Jacquet P, Jelinek JS, Chang D, Sugarbaker PH. Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery. J Am Coll Surg 1995;181:530-538.
Sulkin TVC, O’Neill H, Amin AI, Moran B. CT in Pseudomyxoma Peritonei: A Review of 17 Cases. Clin Radiol 2002;57:608-613.
Yan TD, Black D, Savady R, Sugarbaker PH. A Systematic Review on the Efficacy of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei. Ann Surg Oncol 2007;14:484-492.
Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. J Clin Oncol 2012;30:2449-2456.
Glehen O, Mohamed F, Sugarbaker PH. Incomplete Cytoreduction in 174 Patients With Peritoneal Carcinomatosis From Appendiceal Malignancy. Ann Surg 2004;240:278-285.